UBS Draws RBC's CHF 50 Target While AlphaValue Cuts to Reduce

Two analysts moved in opposite directions on UBS this week, and their split captures the central tension in the stock: a bank posting strong returns against a regulatory calendar that could still rewrite the math.

RBC Capital Markets raised its price target to CHF 50 from CHF 44 on Friday and kept an "Outperform" rating. Days earlier, AlphaValue/Baader Europe had gone the other way, cutting its recommendation from "Add" to "Reduce" and trimming its target to CHF 41.70 from CHF 44.20. The gap between the two targets — more than CHF 8 — is essentially a bet on how much additional capital Bern will demand.

A quarter that supports the bulls

The operating case rests on results UBS published on October 28 for the third quarter of 2026. Net profit came in at USD 2.7 billion, and return on CET1 capital reached 14.8%. Management also said it expects to exceed its own profitability target for 2026.

Cost cuts are running ahead of plan. UBS now guides toward gross savings of USD 13.7 billion, above its earlier target of roughly USD 13.5 billion, and had already booked USD 13.2 billion in gross savings by the time it reported.

Integration of Credit Suisse is nearing completion, according to Bloomberg, and the bank has shed around 200 London positions in recent weeks, hitting wealth management and the investment bank among other areas.

The capital question that divides the analysts

What separates a CHF 50 target from a CHF 41.70 one is the size of the extra equity buffer UBS may be forced to hold. More tied-up capital would weigh on returns even if earnings hold steady; a lighter requirement would make the current profit run rate look considerably more attractive.

A possible reprieve surfaced on Wednesday. A member of the National Council proposed valuing foreign UBS units more conservatively when calculating the additional capital requirement, a shift that could shrink the threatened increase by USD 16 billion. Bloomberg reported the proposal; whether it commands political support, and how far it would actually lower the capital bill, remains unresolved.

The next concrete checkpoint is the detailed deliberation scheduled for November 23 and 24 in the WAK-N, the National Council's economic affairs committee. Investors will be watching in particular whether the foreign-unit valuation proposal gains traction there.

Takeover chatter and a political warning

UBS shares rose on Thursday, with media reports attributing the move to the capital-relief talk and to unconfirmed takeover speculation. The X news service "Wall St Engine" floated the idea of a sale of UBS's foreign business to Morgan Stanley at a price of as much as USD 138 billion, including a 25% premium. Neither a deal nor an official transaction process has been confirmed.

The political stakes were underlined separately. Zurich government president Carmen Walker Späh warned, according to Reuters, that a departure of UBS would have serious consequences for tax revenue and for Swiss companies — a reminder that the location debate carries weight beyond the bank's own balance sheet.

For now, the investment case hinges on whether strong earnings can outrun whatever capital rules emerge. A favorable committee outcome would let profitability take center stage; a strict one would put the 14.8% return under a harsher light.